The current PDSB market cap is 102.66M. The company's latest EPS is USD -1.3804 and P/E is -2.39.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.28M | -18.82M | -9.42M | -12.7M | -10.52M |
Net Income | -7.42M | -19.14M | -9.66M | -11.54M | -10.85M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -21.04M | -14.9M | -21.44M | -41.67M | -43.05M |
Net Income | -7M | -14.85M | -16.92M | -40.86M | -42.94M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 74.89M | 77.01M | 68.45M | 63.75M | 57.19M |
Total Liabilities | 27.83M | 33.01M | 27.44M | 31.31M | 32.7M |
Total Equity | 47.06M | 44M | 41.01M | 32.44M | 24.48M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.49M | 30.89M | 67.2M | 77.01M | 59.39M |
Total Liabilities | 2.79M | 3.76M | 3.99M | 33.01M | 33.26M |
Total Equity | 11.7M | 27.13M | 63.21M | 44M | 26.13M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.18M | -25.71M | -13.19M | -18M | -25.18M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 24.58M | 34.29M | 4.57M | 4.81M | 5.61M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.07M | -13.15M | -12.49M | -25.71M | -33.64M |
Investing | 29.38M | N/A | N/A | N/A | N/A |
Financing | 750k | 29.83M | 48.89M | 34.29M | 16.38M |
Market Cap | 102.66M |
Price to Earnings Ratio | -2.39 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.81 |
Price to Book Ratio | 3.93 |
Dividend Yield | - |
Shares Outstanding | 31.11M |
Average Volume (1 week) | 679.79k |
Average Volume (1 Month) | 822.31k |
52 Week Change | -46.25% |
52 Week High | 10.27 |
52 Week Low | 2.59 |
Spread (Intraday) | 0.01 (0.3%) |
Company Name | PDS Biotechnology Corporation |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.pdsbiotech.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.